MENU
+Compare
ATRC
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$34.73
Change
-$0.08 (-0.23%)
Capitalization
1.73B

ATRC AtriCure Forecast, Technical & Fundamental Analysis

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors... Show more

ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATRC with price predictions
Oct 03, 2025

ATRC's Stochastic Oscillator remains in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for ATRC moved above the 200-day moving average on September 16, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 258 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATRC as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on September 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATRC moved below its 50-day moving average on September 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ATRC crossed bearishly below the 50-day moving average on October 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.724) is normal, around the industry mean (10.969). P/E Ratio (0.000) is within average values for comparable stocks, (54.450). ATRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.741). ATRC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.296) is also within normal values, averaging (14.774).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATRC is expected to report earnings to fall 12.54% to -11 cents per share on October 29

AtriCure ATRC Stock Earnings Reports
Q3'25
Est.
$-0.11
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.02
The last earnings report on July 29 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 54.82K shares outstanding, the current market capitalization sits at 1.73B.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7555 Innovation Way
Phone
+1 513 755-4100
Employees
1200
Web
https://www.atricure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSCRX15.720.09
+0.58%
Putnam Small Cap Value R
MGLMX16.850.09
+0.54%
MFS Global Real Estate R4
GQEFX36.690.16
+0.44%
GMO Quality IV
FLUIX29.980.13
+0.44%
Fidelity Advisor Stk Selec Lg Cp Val I
BBISX34.900.14
+0.40%
Sterling Capital Behav Lg Cp Val Eq Intl

ATRC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+1.52%
CERS - ATRC
42%
Loosely correlated
+3.97%
SIBN - ATRC
41%
Loosely correlated
+1.33%
ISRG - ATRC
40%
Loosely correlated
+2.11%
IRMD - ATRC
38%
Loosely correlated
+0.23%
TMCI - ATRC
37%
Loosely correlated
+1.60%
More

Groups containing ATRC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+1.52%
Pharmaceuticals: Other
industry (103 stocks)
26%
Poorly correlated
+0.41%
Pharmaceuticals
industry (386 stocks)
26%
Poorly correlated
+0.12%